Back to Nephrology

OUR EXPERTISE AND SERVICES AVAILABLE IN

Polycystic Kidney Disease

Overview

Spherix’s coverage of the polycystic kidney disease market leverages quarterly trackers with patient chart audits to provide insights into evolving treatment trends for ADPKD, as well as ARPKD, patients. Research covers Issues such as current treatment methods, best practices in disease tracking and imaging, and potential for new pipeline products.

Services Available

Trending market evolution

  • Polycystic Kidney Disease (US) - quarterly, n=100

Exploring the patient journey

  • Polycystic Kidney Disease (US) - n=750 patient charts

Benchmarking new brand performance

  • Venglustat (Sanofi) Polycystic Kidney Disease (US)*

*Pending approvals and launch

Gauging impact of disruptive events

  • Multi-Specialty Impact of COVID-19 (US)

Learn more about our services

  • HOW CAN WE PARTNER TOGETHER?

    Get more information on Polycystic Kidney Disease Coverage